| BMC Veterinary Research | |
| Pharmacokinetics/pharmacodynamics of marbofloxacin in a Pasteurella multocida serious murine lung infection model | |
| Research Article | |
| Zhenling Zeng1  Ying Qu1  Changfu Cao1  Zhenzhen Qiu1  Yan Lu1  Meizhen Sun1  Chaoping Liang1  | |
| [1] National Reference Laboratory of Veterinary Drug Residues (SCAU), College of Veterinary Medicine, South China Agriculture University, Guangzhou, China; | |
| 关键词: Marbofloxacin; Pharmacokinetics/Pharmacodynamics; Pasteurella multocida; Mouse-lung model; | |
| DOI : 10.1186/s12917-015-0608-1 | |
| received in 2015-04-21, accepted in 2015-11-24, 发布年份 2015 | |
| 来源: Springer | |
PDF
|
|
【 摘 要 】
BackgroundMarbofloxacin is a third-generation fluoroquinolone developed solely for veterinary medicine with a broad spectrum of antibacterial activity against some Gram-positive and most Gram-negative bacteria, including the bovine respiratory tract pathogen, Pasteurella multocida. The objective of our study was to elucidate the pharmacokinetics and pharmacodynamics of marbofloxacin in a Pasteurella multocida infected murine lung model, and to estimate the magnitudes of pharmacokinetics-pharmacodynamics parameters associated with various effects.ResultsThe pharmacokinetic studies revealed marbofloxacin kinetics in infected mice were linear over a dose ranging from 1.25 to 10 mg/kg of body weight. The protein binding in the plasma of neutropenic infected mice was 29.77 %. The magnitudes of the ratio of the free-drug area under the concentration-time curve over 24 h to MIC (fAUC0-24h/MIC) associated with static effect, a 2 log10 reduction and a 3 log10 reduction of bacterial counts were 40.84, 139.34, and 278.08 h, respectively.ConclusionsBased on the dose range study, marbofloxacin exhibited concentration-dependent killing and the fAUC/MIC was the PK/PD index that correlated best with efficacy (R2 = 83 %). On the basis of a bactericidal effect goal of fAUC0-24h/MIC of 278.08 h, if marbofloxacin is used for the treatment of P. multocida serious lung infection with an MIC90 of 0.12 μg/ml, the current dose (2 mg/kg) would fail to achieve a bactericidal effect. It would benefit from higher doses (4 ~ 6 mg/kg) than those commonly used in clinical practice.
【 授权许可】
CC BY
© Qu et al. 2015
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| RO202311103498852ZK.pdf | 653KB |
【 参考文献 】
- [1]
- [2]
- [3]
- [4]
- [5]
- [6]
- [7]
- [8]
- [9]
- [10]
- [11]
- [12]
- [13]
- [14]
- [15]
- [16]
- [17]
- [18]
- [19]
- [20]
- [21]
- [22]
- [23]
- [24]
- [25]
- [26]
PDF